Peter Forsell
Tracked across 2 events · 22 articles · First seen Aug 14, 2026 · Last active Aug 21, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Implantica AG (publ), a medtech company listed on Nasdaq First North Premier Growth Market, announced that it will publish its interim report for the second quarter of 2026 on August 21, 2026, at 8:00 a.m.…
Impact: Peter Forsell, CEO of Implantica, is scheduled to speak at the Q2 2026 presentation, representing the company's leadership and discussing results.
Aug 14, 2026 · 6 articles
Regulatory
Implantica AG, a Liechtenstein-based medtech company, announced on August 20-21, 2026, that the U.S. United States — Food and Drug Administration (FDA) granted Premarket Approval (PMA) for RefluxStop, its implant-based treatment for gastroesophageal reflux disease…
Impact: Peter Forsell, CEO and founder of Implantica, announced the FDA approval and outlined the company's U.S. launch strategy. His leadership is central to the company's execution and growth.
Aug 20, 2026 · 16 articles
ERGEN INTELLIGENCE
Track Peter Forsell live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard